Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Therapy with tyrosine kinase inhibitor lenvatinib in radioactive iodine-naive advanced differentiated thyroid cancer INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY Sukumar, J., Moore, W., Khan, S. A. 2019; 6 (4)
View details for DOI 10.2217/ije-2019-0007
View details for Web of Science ID 000512669200002